1031 ET - As Intuitive Surgical shares drop 11% following 2Q earnings, analysts at Oppenheimer say competitive headwinds lie ahead and pricing dynamics may be unsustainable in the long term. Though Intuitive posted both higher 2Q profits and sales, Oppenheimer says the company is likely to face competition from homegrown Chinese systems and its shift to extended use instruments is bound to pressure FY27 growth. The analysts also pointed to slowing procedure growth in the U.S., which the company reported was 12% year over year from 14% in 1Q. (grace.yoon@wsj.com)
(END) Dow Jones Newswires
July 17, 2026 10:31 ET (14:31 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments